Estratificación del riesgo cardiovascular en pacientes con sobrepeso u obesidad en prevención primaria. Implicaciones en la utilización de estatinas
Tài liệu tham khảo
Imes, 2014, The obesity epidemic: The United States as a cautionary tale for the rest of the world, Curr Epidemiol Rep., 1, 82, 10.1007/s40471-014-0012-6
Basterra-Gortari, 2007, Tendencias de la obesidad, diabetes mellitus, hipertensión e hipercolesterolemia en España (1997-2003), Med Clin (Barc)., 129, 405, 10.1157/13110464
Bastien, 2014, Overview of epidemiology and contribution of obesity to cardiovascular disease, Prog Cardiovasc Dis, 56, 369, 10.1016/j.pcad.2013.10.016
Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies, Lancet., 373, 1083, 10.1016/S0140-6736(09)60318-4
Chen, 2013, Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: Pooled analysis of prospective data from the Asia Cohort Consortium, BMJ., 347, f5446, 10.1136/bmj.f5446
Voulgari, 2011, Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals, J Am Coll Cardiol., 58, 1343, 10.1016/j.jacc.2011.04.047
Griera Borrás, 2014, ¿Existe el obeso sano?, Endocrinol Nutr., 61, 47, 10.1016/j.endonu.2013.03.010
Kramer, 2013, Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis, Ann Intern Med., 159, 758, 10.7326/0003-4819-159-11-201312030-00008
Wilson, 1998, Prediction of coronary heart disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837
Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project, Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3
Stone, 2014, ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol., 63, 2889, 10.1016/j.jacc.2013.11.002
Masson, 2014, Estratificación del riesgo cardiovascular utilizando diferentes puntajes de riesgo en prevención primaria. Implicancias en la indicación de estatinas, Rev Arg Cardiol, 10.7775/rac.es.v82.i6.4527
Nambi, 2010, Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study, J Am Coll Cardiol, 55, 1600, 10.1016/j.jacc.2009.11.075
Masson, 2011, Aplicabilidad clínica de la función de Framingham a 30 años. Utilidad en la estratificación del riesgo cardiovascular y en el diagnóstico de placa aterosclerótica carotídea, Rev Esp Cardiol, 64, 305, 10.1016/j.recesp.2010.11.006
Masson, 2013, Estimación del riesgo cardiovascular y detección de ateromatosis carotídea subclínica en mujeres posmenopáusicas de mediana edad, Rev Argent Cardiol, 81, 322, 10.7775/rac.es.v81.i4.1524
2001, Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486
2012, European Heart Journal, 33, 1635, 10.1093/eurheartj/ehs092
Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310
Lau, 2007, 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary], CMAJ, 176, S1, 10.1503/cmaj.061409
Tsigos, 2008, Management of obesity in adults: European clinical practice guidelines, Obesity Facts, 1, 106, 10.1159/000126822
Jensen, 2014, 2013 AHA/ACC/TOS Guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society, J Am Coll Cardiol., 63, 2985, 10.1016/j.jacc.2013.11.004
2013
Largent, 2013, Reduction in Framingham risk of cardiovascular disease in obese patients undergoing laparoscopic adjustable gastric banding, Adv Ther., 30, 684, 10.1007/s12325-013-0045-0
Mora, 2005, Interaction of body mass index and framingham risk score in predicting incident coronary disease in families, Circulation., 111, 1871, 10.1161/01.CIR.0000161956.75255.7B
Silber, 2008, Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT), Med Klin (Munich)., 103, 638, 10.1007/s00063-008-1103-2
Cristóbal, 2005, Comparison of coronary risk estimates derived using the Framingham and REGICOR equations, Rev Esp Cardiol., 58, 910, 10.1157/13078127
Solomon, 2012, cObesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: A cross-sectional study, Arthritis Res Ther., 14, R67, 10.1186/ar3784
Krämer, 2013, ¿Sirven los marcadores de riesgo no tradicionales en la diferenciación del riesgo cardiovascular en adultos jóvenes con exceso de peso?, Rev Med Chile, 141, 1026, 10.4067/S0034-98872013000800009
Brugts, 2009, The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomised controlled trials, BMJ., 338, b2376, 10.1136/bmj.b2376
Sattar, 2003, Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study, Circulation, 108, 414, 10.1161/01.CIR.0000080897.52664.94
Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med., 359, 2195, 10.1056/NEJMoa0807646